PRG Deep Sleep Blend 30mg – Pinealon, Epitalon & Selank Research Peptide Blend

PRG Deep Sleep Description

The deep sleep peptide blend combines Pinealon, Epitalon, and Selank to support restorative sleep-associated signaling pathways. Pinealon is a short peptide studied for its role in maintaining neuronal cellular function and circadian-associated biological rhythms. Epitalon is investigated for its interaction with pineal signaling pathways and melatonin-regulation-associated systems. Selank is studied for its modulation of stress-response and GABAergic signaling pathways without strong sedative-like activity. Together, the three peptides interact with multiple brain and neuroendocrine systems involved in sleep depth, sleep architecture, and circadian regulation. The blend supports endogenous biological mechanisms associated with transition into and maintenance of deep-sleep-associated stages. Rather than acting through direct sedative suppression, it primarily targets intracellular signaling pathways and neuroregulatory systems within neuronal cells. Animal research has demonstrated changes in sleep-pattern-associated behavior and calmer cortical signaling activity following administration of these peptides. Human observational studies, particularly in older adult populations, have reported improvements in sleep-regularity-associated parameters and morning-restoration-associated observations. The overall research focus of the blend centers on promoting more stable, high-quality deep-sleep-associated signaling through endogenous regulatory pathways.

Molecular Mechanisms of Action at the Cellular and Subcellular Level

Pinealon (Glu-Asp-Arg) is a tripeptide bioregulator whose small size allows passive diffusion across lipid bilayers, including the plasma membrane and nuclear envelope. Once inside the nucleus it interacts directly with specific DNA sequences, modulating transcription of genes involved in neuronal differentiation, repair, and antioxidant defense. In cerebellar granule neurons and cortical cell models this leads to upregulated expression of proteins such as nestin and β-tubulin III, while simultaneously enhancing transcription of genes encoding superoxide dismutase isoforms and glutathione peroxidase.

The peptide restricts accumulation of reactive oxygen species (ROS) generated by receptor-dependent or independent oxidative stressors, delays ERK1/2 phosphorylation kinetics, and reduces necrotic and apoptotic signaling under hypoxic or toxin-associated stress conditions. By stabilizing mitochondrial function and limiting caspase-3 and p53-mediated pathways in stressed neurons, Pinealon preserves synaptic integrity and supports serotonin biosynthetic capacity in cortical neurons, providing an upstream substrate pool for melatonin synthesis. These actions converge on pineal-modulated circadian output because the peptide also restores pinealocyte responsiveness, indirectly reinforcing the suprachiasmatic nucleus–pineal axis without acting as a direct melatonin mimetic.

Epitalon (Ala-Glu-Asp-Gly) is a tetrapeptide modeled on pineal-derived sequences that likewise crosses cellular and nuclear membranes to engage DNA regulatory elements. Its primary molecular target in pinealocytes is transcriptional activation of arylalkylamine N-acetyltransferase (AANAT), the rate-limiting enzyme in melatonin biosynthesis, via increased phosphorylation of CREB and subsequent promoter engagement.

In parallel, Epitalon induces telomerase reverse transcriptase (hTERT) expression and enzymatic activity, contributing to telomere-maintenance-associated signaling and modulation of replicative senescence pathways. This telomerase upregulation occurs through epigenetic modulation, including altered histone-acetylation patterns at telomeric regions and suppression of p53-associated senescence signaling.

In aged pineal tissue the peptide normalizes diurnal melatonin-associated signaling patterns by restoring nocturnal amplitude rhythms and reducing aberrant daytime cortisol-associated fluctuations, thereby re-entraining peripheral clock genes (PER, CRY, CLOCK/BMAL1). Antioxidant effects arise from both direct ROS modulation in pineal mitochondria and indirect upregulation of endogenous antioxidant enzymes, while the peptide also modulates interleukin-2 mRNA and thymocyte-associated mitogenic signaling, linking neuroendocrine and immune circadian coordination.

The net result is reinforcement of the pineal–hypothalamic feedback loop associated with deeper non-REM sleep-state signaling through enhanced melatonin-associated GABAergic tone in thalamic and cortical networks.

Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro), a synthetic heptapeptide analog of the immunopeptide tuftsin, exerts its effects primarily at the plasma-membrane level while also influencing nuclear transcription. It functions as a positive allosteric modulator of GABA-A receptors, altering GABA-binding kinetics without occupying the benzodiazepine site. Radioligand studies demonstrate increased specific [³H]GABA binding and shifts in receptor-subunit stoichiometry favoring inhibitory chloride conductance.

This modulation is rapid and concentration-dependent, producing gene-expression changes in the frontal cortex within one hour, including upregulation of GABA receptor α- and β-subunits, GABA transporters, and ion-channel-associated genes, with transcriptional overlap resembling exogenous GABA signaling itself.

Selank simultaneously inhibits neutral endopeptidase and aminopeptidase N, prolonging synaptic persistence of endogenous enkephalins and thereby amplifying μ- and δ-opioid receptor-associated signaling that dampens stress-associated hypothalamic-pituitary-adrenal-axis activity.

In hippocampal and cortical neurons it rapidly elevates brain-derived neurotrophic factor (BDNF) mRNA and protein via CREB-dependent promoter IV activation, enhancing TrkB autophosphorylation, dendritic-spine density, and synaptic-plasticity-associated signaling pathways. Serotonergic and dopaminergic gene networks are also modulated, including 5-HT receptor subtypes and dopamine transporter pathways, reducing hyperarousal-associated signaling without pronounced sedative or amnestic effects.

Collectively these changes lower cortical excitability thresholds, facilitate sleep-spindle-associated oscillations, and stabilize transitions into slow-wave-sleep-associated states.

Synergistic Molecular Integration of the Blend

When Pinealon, Epitalon, and Selank are combined, their actions converge at multiple nodes of the sleep-regulatory network. Epitalon restores pineal melatonin-associated output signaling at the enzymatic and transcriptional level, while Pinealon amplifies these effects by protecting pinealocytes and cortical neurons from oxidative stress-associated damage and by supporting serotonin availability for melatonin-associated pathways.

Selank lowers the arousal set-point through GABA-A allosteric modulation and enkephalin stabilization, allowing melatonin-gated thalamo-cortical oscillatory signaling to propagate into deeper delta-wave-associated activity without excessive interference from stress-associated noradrenergic or CRF pathways.

At the nuclear level the two bioregulators (Pinealon and Epitalon) coordinate gene-expression programs involving telomerase maintenance, neuronal antioxidant signaling, and cellular repair pathways, while Selank contributes BDNF-associated plasticity signaling that consolidates these effects into longer-term synaptic remodeling-associated adaptations.

The blend therefore does not simply suppress wakefulness-associated signaling but instead recalibrates pineal–cortical–limbic regulatory networks involved in circadian rhythm synchronization, sleep-depth-associated signaling, sleep-spindle density, and REM/non-REM cycling at the level of ion-channel regulation, histone-acetylation-associated pathways, and neurotrophin signaling.

Potential Research Applications in Sleep and Circadian Biology

The molecular profile positions the blend for research involving biological systems where deep-sleep-associated signaling is disrupted by circadian dysregulation, oxidative neuronal burden, or hyperarousal-associated pathways.

Age-associated decline in pineal melatonin signaling, telomere attrition in pinealocytes, and progressive cortical oxidative stress contribute to fragmentation of slow-wave-sleep-associated architecture; the blend addresses each of these biological nodes through distinct but convergent mechanisms.

In stress-associated insomnia models, the combined GABA-A/BDNF signaling effects of Selank alongside circadian reinforcement from Pinealon and Epitalon may support restoration of sleep-efficiency-associated signaling without reliance on direct sedative suppression pathways.

Neurodegenerative research models may also benefit from the blend’s neuroprotective gene-expression programs and mitochondrial-stabilization-associated signaling, potentially helping preserve sleep architecture in age-associated neurobiological decline.

Additional exploratory research areas include shift-work-associated circadian disruption, jet-lag-associated desynchronization, maintenance of cognitive-performance-associated signaling during sleep restriction, nocturnal immune-regulation pathways, and metabolic signaling associated with growth-hormone pulsatility during deep sleep.

Because the peptides preserve rather than override endogenous circadian rhythms, the blend aligns conceptually with precision neuroendocrine and sleep-biology peptide research.

Summary of Animal and Human Investigations

In rodent models Pinealon administration to aged or hypoxic animals improved sleep-continuity-associated behavior, reduced cortical ROS accumulation, and preserved dendritic-spine morphology in hippocampal and cortical tissue models.

Epitalon studies in aged rats and mice demonstrated increased pineal AANAT activity, telomere-maintenance-associated signaling across multiple tissues, and normalization of circadian locomotor-associated behavior. Primate studies in aged rhesus monkeys demonstrated increased nocturnal melatonin-associated output amplitude and restoration of physiologic cortisol-associated nadir patterns, alongside stabilization of glucose and lipid-associated metabolic parameters.

Selank research in rodent anxiety and stress paradigms produced rapid reductions in hyperlocomotion-associated signaling, elevated hippocampal BDNF expression, and altered frontal-cortex GABAergic gene-expression patterns within hours of exposure.

Combined peptide approaches in neuroprotection-associated animal assays demonstrated additive preservation of neuronal viability under oxidative challenge conditions.

Human investigations, particularly involving older adult cohorts, documented that Epitalon-type pineal peptides restored nocturnal melatonin-associated profiles to levels resembling younger biological patterns, improved subjective sleep-depth-associated observations, and normalized circadian-phase markers.

Pinealon observational studies involving traumatic-brain-injury-associated and age-related cognitive-change-associated populations reported improvements in memory-consolidation-associated signaling and daytime-alertness-related parameters consistent with enhanced overnight neuronal repair-associated activity.

Selank has also been investigated in generalized-anxiety-associated populations, demonstrating reductions in Hamilton Anxiety Scale-associated observations without significant sedation, memory impairment, or withdrawal-associated patterns; secondary sleep-associated improvements were noted in subjects where insomnia-related signaling was linked to hyperarousal and stress pathways.

Small-scale observational datasets involving multi-peptide regimens in elderly subjects with sleep-maintenance-associated difficulties suggest additive improvements in polysomnographic slow-wave-sleep-associated percentages and next-day cognitive-performance-associated parameters.

Across these studies the peptides demonstrated favorable tolerability profiles, with molecular readouts—including telomere-associated markers, antioxidant-enzyme activity, and GABA-binding-associated signaling—aligning with preclinical mechanistic findings.

While large-scale randomized controlled investigations focused specifically on the exact three-peptide blend remain limited, the complementary mechanistic and observational data continue to support scientific interest in the formulation for deep-sleep-associated and circadian-regulation-associated research.

In summary, the Pinealon–Epitalon–Selank blend operates through an integrated network involving nuclear gene regulation, receptor allostery, antioxidant signaling, and enzymatic circadian control pathways to support deep-sleep-associated neuroendocrine homeostasis. Its relevance extends across age-associated, stress-associated, and neurodegenerative sleep-biology research models through interaction with upstream biochemical signaling systems rather than downstream symptom-suppression pathways.

The PRG Deep Sleep formulation is a proprietary peptide blend of Pinealon (Glu-Asp-Arg / EDR tripeptide), Epitalon (Ala-Glu-Asp-Gly / AEDG tetrapeptide), and Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro / TKPRPGP heptapeptide) supplied in acetate salt form, which is the standard presentation for these synthetic peptides to optimize aqueous solubility, lyophilization stability, and handling in biochemical and synthesis workflows.

As a proprietary mixture of the acetate salts of Pinealon, Epitalon, and Selank, it retains no single assigned CAS number and has no unified molecular formula. The acetate salts consist of the individual peptide bases with acetate counterions incorporated according to the net positive charge contributed by basic residues and purification conditions.

Neurotrophic Peptides in Cognitive Research

Explore how compounds such as Epithalon, Selank, and Pinealon are discussed in cognitive and neurotrophic research in our article: Best Neurotrophic Peptides for Cognitive Research and Brain Support.